Clinical trial Recruiting at 1 site Interventional Ages 18 to 65

Comparing Maitland rotation mobilization versus Mulligan spinal mobilization with leg movement for lumbar radiculopathy

Official title: Comparative Effects of Maitland's Rotation Mobilization and Mulligan's Spinal Mobilization With Leg Movement on Lumbar Radiculopathy

Run by Foundation University Islamabad · NCT07050966 · Data updated 2026-11-12

This test compares Maitland rotation mobilization and Mulligan spinal mobilization with leg movement to see which reduces pain and improves motion for adults with chronic lumbar radiculopathy.

Quick facts

Study typeInterventional
Ages18 Years to 65 Years
SexAll
Enrollment48 (estimated)
SponsorFoundation University Islamabad
Academic / other
Locations1 site (Islamabad)
StatusRecruiting
StartedJuly 15, 2024
Main results expectedJune 30, 2025
Study endsJune 30, 2025
Registry record updatedJuly 3, 2025
Trial IDNCT07050966 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18–65 with chronic (≥3 months) unilateral lumbar radiculopathy, an NPRS pain score between 5 and 7, who are ambulant and can attend in-person treatments at the study site.

Probably not a fit

People with other spine conditions (failed back surgery, spondylolisthesis, spinal stenosis), non-ambulant patients, those on anticoagulants, or pregnant women are excluded and unlikely to benefit from participation.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized controlled trial assigns adults with chronic unilateral lumbar radiculopathy to one of two treatment groups: Mulligan's spinal mobilization with leg movement plus lower limb neurodynamic mobilization, or Maitland's lumbar rotation mobilization plus the same neurodynamic technique. Treatments are delivered in clinic at Foundation University College of Physical Therapy and outcomes are measured for pain, lumbar range of motion, and functional mobility. Eligible participants are ambulant adults aged 18–65 with symptoms for at least 3 months and an NPRS pain score between 5 and 7. The study compares short- and longer-term changes to identify which mobilization approach provides more durable benefit.

Why it matters

Potential benefit: If successful, the results could help clinicians choose a manual therapy approach that gives more sustained pain relief and improved mobility for people with lumbar radiculopathy.

How similar studies have gone: Both Maitland and Mulligan mobilization techniques have shown short-term symptom improvements in prior studies, but direct head-to-head comparisons for lasting effects in lumbar radiculopathy are limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age: 18-65 years

  * Both Males and Females
  * Participants with a diagnosis of chronic (≥3 months) lumbar unilateral radiculopathy referred from Fauji Foundation Hospital, Rawalpindi
  * NPRS score of \> 5 and \< 8

Exclusion Criteria:

* Diagnosis of other back conditions (e.g. failed back surgery syndrome, spondylosis, spondylolisthesis, and spinal stenosis, non-specific low back pain, and fracture)

  * Non ambulant/wheelchair-bound or having cauda equina syndrome
  * Patient taking anticoagulants
  * Pregnant Females

Where it's running

  • Foundation University College of Physical Therapy
    Islamabad, Pakistan
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.